Keith Lavan
2020
In 2020, Keith Lavan earned a total compensation of $462.5K as Chief Financial Officer at Petros Pharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Salary | $316,856 |
| Other | $95,602 |
| Total | $462,458 |
Lavan received $316.9K in salary, accounting for 69% of the total pay in 2020.
Lavan also received $50K in bonus and $95.6K in other compensation.
Rankings
In 2020, Keith Lavan's compensation ranked 11,232nd out of 13,090 executives tracked by ExecPay. In other words, Lavan earned more than 14.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,232 out of 13,090 | 14th |
Division Manufacturing | 4,805 out of 5,618 | 15th |
Major group Chemicals And Allied Products | 1,992 out of 2,251 | 12th |
Industry group Drugs | 1,739 out of 1,951 | 11th |
Industry Pharmaceutical Preparations | 1,285 out of 1,456 | 12th |
Source: SEC filing on November 22, 2021.
Lavan's colleagues
We found four more compensation records of executives who worked with Keith Lavan at Petros Pharmaceuticals in 2020.